OPTION CARE HEALTH INC

OPTION CARE HEALTH INC

Option Care Health (OPCH) is a US-based provider of home and alternate-site infusion services, supplying complex infusion therapies and related services to patients outside traditional hospital settings. The company partners with payers, providers and pharmaceutical manufacturers to deliver treatments for chronic and acute conditions, aiming to lower costs by shifting care to lower-cost settings. Key drivers for investors to watch include the secular shift towards outpatient care, an ageing population that increases demand for infusion therapies, and contract wins with payers and drug makers. Risks include reimbursement pressure, regulatory scrutiny, operational complexity and labour shortages, which can affect margins and volumes. With a market capitalisation of about $4.58bn, Option Care’s prospects depend on successful integration of acquired businesses, margin management and negotiating favourable terms with payers. This information is educational and not personalised advice; investors should review the latest filings, financial statements and seek professional guidance before acting.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Option Care Health's stock, anticipating it will reach a higher price.

Above Average

Financial Health

Option Care Health is generating solid revenue and cash flow, indicating strong operational performance.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring OPCH

Walgreens Restructuring Explained: Investment Shifts

Walgreens Restructuring Explained: Investment Shifts

Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.

Published: September 2, 2025

Explore Basket
At-Home Treatment Revolution | FDA Approval Impact

At-Home Treatment Revolution | FDA Approval Impact

The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug signals a major shift in chronic disease management. This creates an investment opportunity in companies that develop advanced drug delivery systems and support at-home patient care.

Published: September 1, 2025

Explore Basket
At-Home Healthcare Stocks Explained | FDA Approval

At-Home Healthcare Stocks Explained | FDA Approval

The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.

Published: August 30, 2025

Explore Basket
Walgreens' Restructuring: A New Healthcare Landscape

Walgreens' Restructuring: A New Healthcare Landscape

Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.

Published: August 29, 2025

Explore Basket
Navigating U.S. Drug Price Reforms

Navigating U.S. Drug Price Reforms

The White House is demanding major pharmaceutical companies slash U.S. drug prices, creating significant market volatility and threatening industry profits. This creates a potential opening for companies that offer cost-saving alternatives, such as generic drug makers and healthcare service providers.

Published: August 5, 2025

Explore Basket
Riding The Regulatory Wave In Healthcare

Riding The Regulatory Wave In Healthcare

The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.

Published: July 25, 2025

Explore Basket
Senior Living Shakeout: Leaders After Genesis

Senior Living Shakeout: Leaders After Genesis

This carefully selected group of stocks represents companies positioned to thrive following Genesis HealthCare's bankruptcy. Handpicked by our analysts, these healthcare providers and REITs stand to gain significant market share as the senior care industry undergoes a major transformation.

Published: July 11, 2025

Explore Basket
Healthcare Billing Integrity

Healthcare Billing Integrity

This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.

Published: July 11, 2025

Explore Basket
Medicaid Politics

Medicaid Politics

Discover companies whose fortunes are closely tied to government healthcare funding decisions. These carefully selected stocks represent businesses with significant exposure to Medicaid, now facing heightened legislative uncertainty after Senator Tillis's retirement.

Published: June 30, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Outpatient care shift

The move from hospitals to home care can lower costs and expand volume, though reimbursement and execution risks may affect outcomes.

🌍

Demographic tailwinds

An ageing population increases demand for chronic therapies delivered at home, yet demand can vary with policy and payer decisions.

⚑

Operational complexity

Success depends on supply-chain, clinical operations and payer contracts; operational missteps or labour shortages could dent margins.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

CHE

Chemed Corp.

Provides hospice and palliative care services to patients facing life-limiting illness

ALHC

Alignment Healthcare, Inc.

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

BKD

Brookdale Senior Living Inc.

A leading owner and operator of senior living communities in the United States.

Frequently asked questions